Crescent Capital BDC, Inc. (NASDAQ:CCAP) Sees Significant Decrease in Short Interest

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totalling 87,700 shares, a decrease of 12.4% from the December 15th total of 100,100 shares. Based on an average daily trading volume, of 105,200 shares, the short-interest ratio is currently 0.8 days.

Wall Street Analysts Forecast Growth

CCAP has been the topic of several recent analyst reports. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They set a "buy" rating and a $20.00 price objective on the stock. Keefe, Bruyette & Woods upped their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $19.17.

Hedge Funds Weigh In On Crescent Capital BDC

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Confluence Investment Management LLC lifted its stake in Crescent Capital BDC by 0.9% in the fourth quarter. Confluence Investment Management LLC now owns 73,839 shares of the company's stock valued at $1,419,000 after acquiring an additional 633 shares during the last quarter. HighTower Advisors LLC boosted its stake in shares of Crescent Capital BDC by 0.5% during the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock worth $2,624,000 after acquiring an additional 768 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth approximately $90,000. XTX Topco Ltd bought a new stake in Crescent Capital BDC in the 2nd quarter valued at $195,000. Finally, Hennion & Walsh Asset Management Inc. lifted its holdings in Crescent Capital BDC by 11.9% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 105,343 shares of the company's stock valued at $2,025,000 after purchasing an additional 11,161 shares during the last quarter. 49.46% of the stock is owned by institutional investors.

Crescent Capital BDC Stock Down 0.1 %

NASDAQ CCAP traded down $0.02 during trading hours on Friday, hitting $19.34. 74,403 shares of the company traded hands, compared to its average volume of 94,750. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26. The business's 50-day moving average is $19.29 and its 200-day moving average is $18.77. The stock has a market capitalization of $716.74 million, a price-to-earnings ratio of 7.58 and a beta of 0.81. Crescent Capital BDC has a twelve month low of $15.91 and a twelve month high of $20.03.

Crescent Capital BDC Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were issued a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 8.69%. The ex-dividend date of this dividend was Tuesday, December 31st. This is an increase from Crescent Capital BDC's previous quarterly dividend of $0.07. Crescent Capital BDC's dividend payout ratio is presently 65.88%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.